Similarly, a study of 282 tissue plasminogen activator (tPA)-treated stroke patients stratified by RDW levels (< 12.9% vs. ≥13%) found no significant differences in 3-month modified Rankin Scale scores [13]. The gene discussed is PLAT; the disease is stroke disorder.